Snake venom metalloproteinases, crotarhagin and alborhagin, induce ectodomain shedding of the platelet collagen receptor, glycoprotein VI

Summary

Glycoprotein (GP)VI, that binds collagen, together with GPIb- IX-V which binds von Willebrand factor, forms an adheso-signalling complex on platelets that initiates thrombus formation in haemostasis and thrombosis. In this study, we show that two snake venom metalloproteinases, crotarhagin and alborhagin, induce ectodomain shedding of GPVI by a mechanism that involves activation of endogenous platelet metalloproteinases. Alborhagin is a viper venom metalloproteinase from Trimeresurus albolabris, while crotarhagin is a previously undescribed toxin from the rattlesnake Crotalus horridus horridus (~60-kDa non-reduced and reduced). Like alborhagin, crotarhagin induces aggregation in human platelet-rich plasma (maximal activity, ~0.3 μg/ ml). Aggregation of washed platelets was inhibited by soluble GPVI ectodomain expressed as an Fc-fusion protein, confirming crotarhagin targeted GPVI. Treating washed platelets with crotarhagin or alborhagin resulted in time-dependent loss of surface GPVI and the appearance of an ~55-kDa soluble GPVI fragment in supernatants. Crotarhagin also induced shedding in GPVItransfected RBL-2H3 cells. Crotarhagin-induced shedding was metalloproteinase-dependent (inhibited by EDTA), but also blocked by inhibitors of GPVI signalling (Src kinase inhibitors, PP1 or PP2, or Syk inhibitor, piceatannol), indicating shedding required GPVI-dependent platelet activation. Together, the data suggest that the rattlesnake metalloproteinase, crotarhagin, and the viper toxin alborhagin, induce GPVI shedding by a mechanism involving activation of endogenous platelet metalloproteinases rather than direct cleavage of GPVI.

Keywords

ADAMS - adhesion receptors - snake venoms - platelet glycoproteins

• References

• 1 Moroi M, Jung SM. Platelet glycoprotein VI: its structure and function. Thromb Res 2004; 114: 221-233.
• 2 Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor?. Blood 2003; 102: 449-461.
• 3 Andrews RK, Berndt MC, López JA. The glycoprotein Ib-IX-V complex. In: Platelets. 2nd ed Academic Press; San Diego: 2006: 145-163.
• 4 Andrews RK, Gardiner EE, Shen Y. et al. Molecules in focus: Glycoprotein Ib-IX-V. Int J Biochem Cell Biol 2003; 35: 1170-1174.
• 5 Kroll MH, Hellums JD, McIntire LV. et al. Platelets and shear stress. Blood 1996; 88: 1525-1541.
• 6 Goto S, Ikeda Y, Saldivar E, Ruggeri ZM. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 1998; 101: 479-486.
• 7 Goto S, Tamura N, Handa S. et al. Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditions. Circulation 2002; 106: 266-272.
• 8 Massberg S, Gawaz M, Gruner S. et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 2003; 197: 41-49.
• 9 Bergmeier W, Piffath CL, Goerge T. et al. The role of platelet adhesion receptor GPIb? far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis. Proc Natl Acad Sci USA 2006; 103: 16900-16905.
• 10 Kleinschnitz C, Pozgajova M, Pham M. et al. Targeting platelets in acute experimental stroke. Impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation 2007; 115: 2323-2330.
• 11 Bigalke B, Lindemann S, Ehlers R. et al. Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome. Eur Heart J 2006; 27: 2165-2169.
• 12 Andrews RK, Berndt MC. Snake venom modulators of platelet adhesion receptors and their ligands. Toxicon 2000; 38: 775-791.
• 13 Andrews RK, Gardiner EE, Shen Y. et al. Structureactivity relationships of snake toxins targeting platelet receptors, glycoprotein Ib-IX-V and glycoprotein VI. Curr Med Chem Cardiovasc Hematolog Agents 2003; 1: 143-149.
• 14 Lu Q, Clemetson JM, Clemetson KJ. Snake venoms and hemostasis. J Thromb Haemost 2005; 3: 1791-1799.
• 15 Kamiguti AS. Platelets as targets of snake venom metalloproteinases. Toxicon 2005; 45: 1041-1049.
• 16 Wijeyewickrema LC, Berndt MC, Andrews RK. Snake venom probes of platelet adhesion receptors and their ligands. Toxicon 2005; 45: 1051-1061.
• 17 Andrews RK, Suzuki-Inoue K, Shen Y. et al. Interaction of calmodulin with the cytoplasmic domain of platelet glycoprotein VI. Blood 2002; 99: 4219-4221.
• 18 Locke D, Liu C, Peng X, Chen H. et al. FcRγ-independent signaling by the platelet collagen receptor glycoprotein VI. J Biol Chem 2003; 278: 15441-15448.
• 19 Suzuki-Inoue K, Tulasne D, Bori-Sanz T. et al. Association of fyn and lyn with the proline rich domain of GPVI regulates intracellular signalling. J Biol Chem 2002; 277: 21561-21566.
• 20 Bori-Sanz T, Inoue KS, Berndt MC. et al. Delineation of the region in the glycoprotein VI tail required for association with the Fc receptor γ-chain. J Biol Chem 2003; 278: 35914-35922.
• 21 Gardiner EE, Arthur JF, Kahn ML. et al. Regulation of platelet membrane levels of glycoprotein VI by a platelet- derived metalloproteinase. Blood 2004; 104: 3611-3617.
• 22 Stephens G, Yan Y, Jandrot-Perrus M. et al. Platelet activation induces metalloproteinase-dependent GPVI cleavage to down-regulate platelet reactivity to collagen. Blood 2005; 105: 186-191.
• 23 Bergmeier W, Rabie T, Strehl A. et al. GPVI downregulation in murine platelets through metalloproteinase- dependent shedding. Thromb Haemost 2004; 91: 951-958.
• 24 Andrews RK, Karunakaran D, Gardiner EE. et al. Platelet receptor proteolysis: a mechanism for down regulating platelet reactivity. Arterioscler Thrombos Vasc Biol 2007; 7: 1511-1520.
• 25 Berndt MC, Karunakaran D, Gardiner EE. et al. Programmed autologous cleavage of platelet receptors. J Thromb Haemost 2007; (Suppl. 01) 212-219.
• 26 Gardiner EE, Karunakaran D, Shen Y. et al. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost 2007; 5: 1530-1537.
• 27 Andrews RK, Gardiner EE, Asazuma N. et al. A novel viper venom metalloproteinase, alborhagin, is an agonist at the platelet collagen receptor GPVI. J Biol Chem 2001; 276: 28092-28097.
• 28 Arthur JF, Matzaris M, Gardiner EE. et al. Glycoprotein (GP)VI is associated with GPIb-IX-V on the membrane of resting and activated platelets. Thromb Haemost 2005; 93: 716-723.
• 29 Andrews RK, Kroll MH, Ward CM. et al. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation. Biochemistry 1996; 35: 12629-12639.
• 30 Miura Y, Takahashi T, Jung SM. et al. Analysis of the interaction of platelet collagen receptor glycoprotein VI (GPVI) with collagen. A dimeric form of GPVI, but not the monomeric form, shows affinity to fibrous collagen. J Biol Chem 2002; 277: 46197-46204.
• 31 Gruner S, Prostredna M, Koch M. et al. Relative antithrombotic effect of soluble GPVI dimer compared with anti-GPVI antibodies in mice. Blood 2005; 105: 1492-1499.
• 32 Shen Y, Romo GM, Dong J-F. et al. Requirement of leucine-rich repeats of GPIbα for shear-dependent and static binding of von Willebrand factor to the platelet membrane GPIb-IX-V complex. Blood 2000; 95: 903-910.
• 33 Shen Y, Cranmer SL, Aprico A. et al. Leucine-rich repeats 2–4 (Leu60-Glu128) of platelet glycoprotein Ibα regulate shear-dependent cell adhesion to von Willebrand factor. J Biol Chem 2006; 281: 26419-26423.
• 34 Ward CM, Andrews RK, Smith AI. et al. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibα. Identification of the sulfated tyrosine/anionic sequence Tyr276-Glu282 of glycoprotein Ibα as a binding site for von Willebrand factor and α-thrombin. Biochemistry 1996; 35: 4929-4938.
• 35 Wijeyewickrema LC, Gardiner EE, Berndt MC. et al. Fractionation of snake venom metalloproteinases by metal ion affinity: a purified cobra metalloproteinase, Nk, from Naja kaouthia binds Ni2+-agarose. Toxicon 2007; 50: 1064-1072.
• 36 Holme S, Murphy S. Quantitative measurement of platelet shape by light transmission studies: application to storage of platelets for transfusion. J Lab Clin Med 1978; 92: 53-64.
• 37 Amit T, Amit T, Hochberg Z. et al. Shedding of growth hormone-binding protein is inhibited by hydroxamic acid-based protease inhibitors: proposed mechanism of activation of growth hormone-binding protein secretase. J Endocrinol 2001; 169: 397-407.
• 38 Allinson TM, Parkin ET, Turner AJ. et al. ADAMs family members as amyloid precursor protein α-secretases. J Neurosc Res 2003; 74: 342-352.
• 39 Rabie T, Strehl A, Ludwig A. et al. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem 2005; 280: 14462-14468.
• 40 Bergmeier W, Piffath CL, Cheng G. et al. Tumor necrosis factor-α-converting enzyme (ADAM17) mediates GPIbα shedding from platelets in vitro and in vivo. Circ Res 2004; 95: 677-683.
• 41 Aktas B, Pozgajova M, Bergmeier W. et al. Aspirin induces platelet receptor shedding via ADAM17 (TACE). J Biol Chem 2005; 280: 39716-39722.
• 42 Erlandsen SL, Greet Bittermann A, White J. et al. High-resolution CryoFESEM of individual cell adhesion molecules (CAMs) in the glycocalyx of human platelets: detection of P-selectin (CD62P), GPI-IX complex (CD42A/CD42bα, bβ), and integrin GPIIbIIIa (CD41/CD61) by immunogold labeling and stereo imaging. J Histochem Cytochem 2001; 49: 809-819.
• 43 Neves-Ferreira AG, Perales J, Fox JW. et al. Structural and functional analyses of DM43, a snake venom metalloproteinase inhibitor from Didelphis marsupialis serum. J Biol Chem 2002; 277: 13129-13137.
• 44 Rocha SL, Lomonte B, Neves-Ferreira AG. et al. Functional analysis of DM64, an antimyotoxic protein with immunoglobulin-like structure from Didelphis marsupialis serum. Eur J Biochem 2002; 269: 6052-6062.
• 45 Perales J, Neves-Ferreira AG, Valente RH. et al. Natural inhibitors of snake venom hemorrhagic metalloproteinases. Toxicon 2005; 45: 1013-1020.